Sustained release heterodisperse hydrogel systems for insoluble

Details Sustained release heterodisperse hydrogel systems for insoluble Sustained release heterodisperse hydrogel systems for insoluble

1997-04-18

1998-12-08

Nutter, Nathan M.

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Capsules

424468, 424488, 514777, 514778, 514779, 514780, 514781, 514964, 514965, A61K 914, A61K 922

Patent

active

058465634

ABSTRACT:
A sustained release pharmaceutical formulation includes a sustained release excipient including a gelling agent, an inert pharmaceutical diluent, an optional cationic cross-linking agent, and a medicament having moderate to poor solubility is disclosed. In certain embodiments, the sustained release excipient is granulated with a solution or suspension of a hydrophobic polymer in an amount effective to slow the hydration of the gelling agent when the formulation is exposed to an environmental fluid. In another embodiment, the tablet is coated with a hydrophobic polymer.

REFERENCES:
patent: 3485847 (1969-12-01), Bossert et al.
patent: 3784684 (1974-01-01), Bossert et al.
patent: 4412986 (1983-11-01), Kawata et al.
patent: 4562069 (1985-12-01), Hegasy et al.
patent: 4665081 (1987-05-01), Doi et al.
patent: 4673564 (1987-06-01), Kawata et al.
patent: 4765990 (1988-08-01), Sugimoto
patent: 4792452 (1988-12-01), Howard et al.
patent: 4803081 (1989-02-01), Falk et al.
patent: 4808413 (1989-02-01), Joshi et al.
patent: 4867985 (1989-09-01), Heafield et al.
patent: 4880623 (1989-11-01), Piergiogio et al.
patent: 4889723 (1989-12-01), Kim et al.
patent: 4892741 (1990-01-01), Ohm
patent: 4894235 (1990-01-01), Kohne et al.
patent: 4904699 (1990-02-01), Bauer
patent: 4942040 (1990-07-01), Ragnarsson et al.
patent: 4973469 (1990-11-01), Mulligan et al.
patent: 4983593 (1991-01-01), Miyajima et al.
patent: 4994276 (1991-02-01), Baichwal et al.
patent: 5007790 (1991-04-01), Shell
patent: 5015479 (1991-05-01), Mulligan et al.
patent: 5051263 (1991-09-01), Barry et al.
patent: 5071642 (1991-12-01), Lahr et al.
patent: 5108757 (1992-04-01), Erdos et al.
patent: 5110602 (1992-05-01), Kim et al.
patent: 5128142 (1992-07-01), Mulligan et al.
patent: 5128143 (1992-07-01), Baichwal et al.
patent: 5135757 (1992-08-01), Baichwal et al.
patent: 5145683 (1992-09-01), Rhodes
patent: 5160734 (1992-11-01), Ganesan et al.
patent: 5264446 (1993-11-01), Hegasy et al.
patent: 5439687 (1995-08-01), Compassi
patent: 5455046 (1995-10-01), Baichwal
patent: 5476654 (1995-12-01), Conte et al.
patent: 5554387 (1996-09-01), Baichwal
patent: 5667801 (1997-09-01), Baichwal
McGinity, J.W., et al., "Dissolution and Uniformity Properties of Ordered Mixes of Micronized Griseofulvin and a Directly Compressible Excipient", Drug Development and Industrial Pharmacy, vol. 11, No. 4, pp. 891-900 (1985).
Helbig, J., et al. "Pharmaceutical oral dosage forms of an active agent capable of forming or releasing bicarbonate ions", Pharmaceuticals, (Abstract-98:221837d), vol. 98, p. 63 (1983).
The Merck Index, pp. 848-849, 9th Ed. (1976).
Chemical Abstracts, vol. 104 (1986) Abstract 174662y.
Chemical Abstracts, vol. 99 (1983) Abstract 128360d.
Chemical Abstracts, vol. 92 (1980) Abstract 135278s.
Chemical Abstracts, vol. 92 (1980) Abstract 82429h.
Chemical Abstracts, vol. 77 (1972) Abstract 39130g.
Chemical Abstracts, vol. 70 (1969) Abstract 17133p.
Chemical Abstracts, vol. 98 (1983) Abstract 221832y.
Alderman, D. A., "A review of cellulose ethers in hydrophilic matrices for oral controlled-release dosage forms", Int. J. Pharm. Tech. & Prod. Mfg., vol. 5, pp. 1-9 (1984).
Haynes, R. Brian, M.D., et al., "Manipulation of the therapeutic regimen to improve compliance: Conceptions and misconceptions", Clinical Pharmacology and Therapeutics, vol. 22, No. 2, (Aug. 1977).
English translation of Japanese Patent Laid-Open-To-Public, publication No. Aug. 1986, publication date Jan. 6, 1986, Japanese Patent Application No. 118,789/1984; Japanese Patent Application date Jun. 9, 1984.
Techniques of Solubilization of Drugs, edited by Samuel H. Yalkowsky, The Upjohn Company, pub. Marcel Dekker, Inc., New York and Basel, pp. 308-315 (1981).
"Crystallization and Granulation", Remington's of Pharmacy, 9th Ed., Chapter XXVII, pp. 208-211, 1950.
Ritschel, Angewandte Biopharmazie, pp. 293-302 (1973).
Sugimoto, I., et al., "Dissolution and Absorption of Nifedipine From Nifedipine-Polyvinylpyrrolidone Coprecipitate", Drug Development and Industrial Pharmacy, vol. 6, No. 2, pp. 137-161 (1980).
Kleinbloesem, M., et al., "Nifedipine: Kinetics and dynamics in healthy subjects", Clin. Pharmacol. Ther., vol. 35, No. 6 pp. 742-749 (1984).
Ramsch, K., et al., "Pharmacokinetics and Metabolism of Nifedipine", Hypertension Supplement II, vol. 5, No. 4, Jul.-Aug. 18-24 (1983).

Affiliated with

Also associated with

Rating

Sustained release heterodisperse hydrogel systems for insoluble does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Sustained release heterodisperse hydrogel systems for insoluble , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sustained release heterodisperse hydrogel systems for insoluble will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-174739